Searched for
PEPTIDE THERAPY
'Mad Max' actor Richard Norton ignored nurse's warning about peptide treatment which he began days before his sudden death last year- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analysts
- Cipla’s US recovery, biosimilar pipeline key to future growth prospects
- Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upsideNuvama Institutional Equities has initiated coverage on Laurus Labs with a ‘Buy’ rating and a target price of Rs 2,520, implying a 24% upsi...16 Oct, 2026, 03.22 PM IST
- Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...13 Oct, 2026, 10.10 AM IST
- Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...12 Oct, 2026, 01.33 AM IST
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...07 Oct, 2026, 05.28 PM IST
- 2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stagePredictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...30 Sep, 2026, 07.16 PM IST
- Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: SourcesHRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...26 Sep, 2026, 12.49 AM IST
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...23 Sep, 2026, 10.37 PM IST
- Growing peptide trend raises safety concerns among doctorsDoctors express concern over popular injectable peptides for various health benefits. They caution that established peptide medicines diffe...06 Sep, 2026, 05.51 PM IST
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...06 Sep, 2026, 01.01 PM IST
- GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...21 Aug, 2026, 08.29 AM IST
- Beauty and the brief: Your cheat sheet to modern skincare, from barrier repair to regenerative treatmentsIf PDRN looks like a typo and exosomes soundlike science fiction, Divya Verma gives you acheat sheet to the language of modern skincare16 Aug, 2026, 10.10 AM IST
- Researchers develop chewing gum that targets HPV and microbes linked to head and neck cancerChewing gum that targets cancer-linked oral bacteria: Researchers developed bioengineered chewing gum targeting head and neck cancer microb...05 Aug, 2026, 05.23 AM IST
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...22 Apr, 2026, 03.31 PM IST
- Cipla plans 4 major respiratory launches by 2026 after beating Q2 estimates with highest-ever quarterly revenue of Rs 7,500+ crCipla Ltd reported a record second-quarter revenue exceeding Rs 7,500 crore, driven by strong demand for its respiratory drugs and a growin...30 Oct, 2025, 01.33 PM IST
- How is India transforming the global biopharma landscape?In 2024, India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T therapy. ...30 Dec, 2024, 11.08 PM IST
- India's pharma sector registers strong Q2 FY25 growth, driven by North America market: ReportThe major pharmaceutical companies of the country reported a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, largely d...25 Nov, 2024, 11.34 AM IST
- Alzheimer's disease may be treated by gene therapy, says new study47.5 mn people are affected by dementia worldwide - of which Alzheimer's is the most common form, researchers said.12 Oct, 2016, 02.37 PM IST
Load More
